Ardent Health Partners, LLC (NYSE:ARDT) Receives $21.91 Consensus PT from Brokerages

Ardent Health Partners, LLC (NYSE:ARDTGet Free Report) has received a consensus recommendation of “Buy” from the twelve ratings firms that are presently covering the company, Marketbeat.com reports. One equities research analyst has rated the stock with a hold rating, nine have given a buy rating and two have assigned a strong buy rating to the company. The average twelve-month price target among brokerages that have issued ratings on the stock in the last year is $21.91.

Several brokerages have recently issued reports on ARDT. Loop Capital assumed coverage on Ardent Health Partners in a research report on Monday, August 12th. They set a “buy” rating and a $18.00 price target on the stock. JPMorgan Chase & Co. began coverage on Ardent Health Partners in a research note on Monday, August 12th. They issued a “neutral” rating and a $18.00 price target on the stock. Morgan Stanley started coverage on shares of Ardent Health Partners in a research note on Monday, August 12th. They set an “overweight” rating and a $27.00 price objective for the company. Truist Financial started coverage on shares of Ardent Health Partners in a research report on Monday, August 12th. They set a “buy” rating and a $21.00 price objective on the stock. Finally, Leerink Partnrs upgraded Ardent Health Partners to a “strong-buy” rating in a report on Monday, August 12th.

Check Out Our Latest Stock Report on Ardent Health Partners

Ardent Health Partners Stock Performance

Shares of NYSE ARDT opened at $17.70 on Friday. The company’s 50-day moving average is $18.58. The company has a current ratio of 1.65, a quick ratio of 1.54 and a debt-to-equity ratio of 0.93. Ardent Health Partners has a fifty-two week low of $15.00 and a fifty-two week high of $20.72.

Ardent Health Partners (NYSE:ARDTGet Free Report) last issued its quarterly earnings results on Wednesday, August 14th. The company reported $0.35 earnings per share for the quarter, topping analysts’ consensus estimates of $0.30 by $0.05. The company had revenue of $1.47 billion during the quarter, compared to analyst estimates of $1.46 billion. On average, sell-side analysts expect that Ardent Health Partners will post 1.26 EPS for the current fiscal year.

Institutional Trading of Ardent Health Partners

A number of institutional investors and hedge funds have recently made changes to their positions in ARDT. Financial Management Professionals Inc. bought a new position in shares of Ardent Health Partners in the 3rd quarter valued at approximately $50,000. Seven Grand Managers LLC bought a new position in shares of Ardent Health Partners in the third quarter valued at approximately $2,298,000. Finally, Allspring Global Investments Holdings LLC acquired a new stake in shares of Ardent Health Partners in the third quarter worth $13,119,000.

Ardent Health Partners Company Profile

(Get Free Report

Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.

See Also

Analyst Recommendations for Ardent Health Partners (NYSE:ARDT)

Receive News & Ratings for Ardent Health Partners Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ardent Health Partners and related companies with MarketBeat.com's FREE daily email newsletter.